Skip to main content

Table 1 Study participant characteristics

From: Genomic alterations in normal breast tissues preceding breast cancer diagnosis

 

Healthy controls (n = 81)

Pre-diagnosis tissues (n = 79)

P value

Age, mean (range)

53.9 (29–73)

53.6 (28–74)

0.837a

BMI, mean (SD)

30.4 (6.3)

30.6 (6.5)

0.904a

Tyrer-Cuzick lifetime risk score, mean (SD)

12.7 (6.7)

13.4 (9.7)

0.594a

Self-reported ethnicity, n (%)

Black

17 (21.0%)

17 (21.5%)

1b

White

62 (76.5%)

60 (75.9%)

 

Others

2 (2.5%)

2 (2.6%)

 

Menopausal status, n (%)

Pre-menopausal

23 (28.4%)

23 (28.8%)

0.476b

Post-menopausal

53 (65.4%)

47 (60.0%)

 

Others

5 (6.2%)

9 (11.2%)

 

Has blood relatives with cancer, n (%)

Yes

43 (53.1%)

44 (55.0%)

1b

No

34 (42.0%)

33 (42.5%)

 
 

NA (4.9%)

NA (2.5%)

 

Time to diagnosis in years, mean (range)

NA

4.7 (0–11)

 

Follow-up time from donation year, mean (range)

6.1 (0–14)

NA

 
  1. aP values determined by two-sample t-test
  2. bP values determined by Fisher’s exact test